These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 7881104)

  • 1. Transcriptional regulation of multidrug resistance in breast cancer.
    Glazer RI; Rohlff C
    Breast Cancer Res Treat; 1994; 31(2-3):263-71. PubMed ID: 7881104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of multidrug resistance through the cAMP and EGF signalling pathways.
    Rohlff C; Glazer RI
    Cell Signal; 1995 Jul; 7(5):431-43. PubMed ID: 8562304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.
    Scala S; Budillon A; Zhan Z; Cho-Chung YS; Jefferson J; Tsokos M; Bates SE
    J Clin Invest; 1995 Aug; 96(2):1026-34. PubMed ID: 7543490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant MCF-7 breast cancer cells.
    Parissenti AM; Gannon BR; Villeneuve DJ; Kirwan-rhude AF; Chadderton A; Glück S
    Int J Cancer; 1999 Sep; 82(6):893-900. PubMed ID: 10446459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the MDR1 promoter by cyclic AMP-dependent protein kinase and transcription factor Sp1.
    Rohlff C; Glazer RI
    Int J Oncol; 1998 Feb; 12(2):383-6. PubMed ID: 9458366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
    Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha.
    Yin Y; Allen PD; Jia L; MacEy MG; Kelsey SM; Newland AC
    Br J Haematol; 2000 Mar; 108(3):565-73. PubMed ID: 10759715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
    Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
    Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.
    Trock BJ; Leonessa F; Clarke R
    J Natl Cancer Inst; 1997 Jul; 89(13):917-31. PubMed ID: 9214671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
    Barrand MA; Bagrij T; Neo SY
    Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining MDR1/P-glycoprotein expression in breast cancer.
    Faneyte IF; Kristel PM; van de Vijver MJ
    Int J Cancer; 2001 Jul; 93(1):114-22. PubMed ID: 11391630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs.
    Jin W; Liu Y; Xu SG; Yin WJ; Li JJ; Yang JM; Shao ZM
    Breast Cancer Res Treat; 2010 Nov; 124(1):39-48. PubMed ID: 20037778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta.
    Gill PK; Gescher A; Gant TW
    Eur J Biochem; 2001 Aug; 268(15):4151-7. PubMed ID: 11488907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of gene amplification in drug resistance.
    Schoenlein PV
    Cancer Treat Res; 1994; 73():167-200. PubMed ID: 7710905
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
    Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDR1, chemotherapy and chromatin remodeling.
    Baker EK; El-Osta A
    Cancer Biol Ther; 2004 Sep; 3(9):819-24. PubMed ID: 15326379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.